Biocryst Pharmaceuticals (BCRX) EPS (Diluted) (2013 - 2026)

Biocryst Pharmaceuticals (BCRX) EPS (Diluted) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 0.31
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.42
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -1.49
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 5.82
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 0.15
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.91
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 0.11
10 Biocryst Pharmaceuticals 2.27 Bn 2.20 Bn 151.04 Mn -2.98

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.98
Dec 31, 2025 1.12
Sep 30, 2025 0.06
Jun 30, 2025 0.02
Mar 31, 2025 0.00
Dec 31, 2024 -0.13
Sep 30, 2024 -0.07
Jun 30, 2024 -0.06
Mar 31, 2024 -0.17
Dec 31, 2023 -0.32
Sep 30, 2023 -0.19
Jun 30, 2023 -0.40
Mar 31, 2023 -0.28
Dec 31, 2022 -0.38
Sep 30, 2022 -0.23
Jun 30, 2022 -0.32
Mar 31, 2022 -0.40
Dec 31, 2021 -0.10
Sep 30, 2021 -328.30
Jun 30, 2021 -242.51